Search results for "Complete"

showing 10 items of 490 documents

Neo-/adjuvant phase III trial to compare intense dose-dense (idd) treatment with EnPC to tailored dose-dense (dt) therapy with dtEC-dtD for patients …

2018

568Background: GAIN-2 compares the effectiveness and safety of a predefined idd regimen (EnPC) vs. a dd regimen with modification of single doses depending on individual hematological and non-hemat...

0301 basic medicineOncologyCancer Researchmedicine.medical_specialtybusiness.industryNeo adjuvant03 medical and health sciencesRegimen030104 developmental biology0302 clinical medicineOncology030220 oncology & carcinogenesisInternal medicinemedicinebusinessPathologicalComplete responseEarly breast cancerJournal of Clinical Oncology
researchProduct

Discontinuation of braf/mek-directed targeted therapy after complete remission of metastatic melanoma : a retrospective multicenter adoreg study

2021

The advent of BRAF/MEK inhibitors (BRAFi/MEKi) has significantly improved progression-free (PFS) and overall survival (OS) for patients with advanced BRAF-V600-mutant melanoma. Long-term survivors have been identified particularly among patients with a complete response (CR) to BRAF/MEK-directed targeted therapy (TT). However, it remains unclear which patients who achieved a CR maintain a durable response and whether treatment cessation might be a safe option in these patients. Therefore, this study investigated the impact of treatment cessation on the clinical course of patients with a CR upon BRAF/MEK-directed-TT. We retrospectively selected patients with BRAF-V600-mutant advanced non-res…

0301 basic medicineOncologyadvanced melanomaCancer Researchmedicine.medical_specialtymedicine.medical_treatmentMedizin610ArticleTargeted therapycomplete response03 medical and health sciences0302 clinical medicinedisease progressionInternal medicineMedicineddc:610second-line immunotherapyneoplasmsComplete responseRC254-282business.industryMelanomaNeoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseasetargeted therapyDiscontinuation030104 developmental biologyOncologyTumor progression030220 oncology & carcinogenesisToxicityCohortSkin cancerbusinessdiscontinuation
researchProduct

Positive impact of ABCB1 polymorphisms in overall survival and complete remission in acute myeloid leukemia: a systematic review and meta-analysis

2015

Positive impact of ABCB1 polymorphisms in overall survival and complete remission in acute myeloid leukemia: a systematic review and meta-analysis

0301 basic medicineOncologymedicine.medical_specialtyATP Binding Cassette Transporter Subfamily BPolymorphism Single Nucleotide03 medical and health sciencesRemission induction0302 clinical medicinehemic and lymphatic diseasesInternal medicinemental disordersGeneticsOverall survivalHumansMedicineSurvival ratePharmacologybusiness.industryRemission InductionComplete remissionMyeloid leukemiaSurvival RateLeukemia Myeloid Acute030104 developmental biology030220 oncology & carcinogenesisMeta-analysisMolecular MedicinebusinessThe Pharmacogenomics Journal
researchProduct

Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy.

2018

Triple negative breast cancer (TNBC) is a heterogeneous disease with distinct molecular subtypes that differentially respond to chemotherapy and targeted agents. The purpose of this study is to explore the clinical relevance of Lehmann TNBC subtypes by identifying any differences in response to neoadjuvant chemotherapy among them. We determined Lehmann subtypes by gene expression profiling in paraffined pre-treatment tumor biopsies from 125 TNBC patients treated with neoadjuvant anthracyclines and/or taxanes +/- carboplatin. We explored the clinicopathological characteristics of Lehmann subtypes and their association with the pathologic complete response (pCR) to different treatments. The g…

0301 basic medicineOncologymedicine.medical_specialtysubtypingmedicine.medical_treatmentCarboplatin03 medical and health scienceschemistry.chemical_compoundpathologic complete responseSubtyping0302 clinical medicineInternal medicinePathologic complete responsemedicineClinical significanceTriple negative breast cancerneoadjuvant therapyReceptorTriple-negative breast cancerNeoadjuvant therapyChemotherapybusiness.industryPhenotypeCarboplatinGene expression profiling030104 developmental biologyOncologychemistry030220 oncology & carcinogenesistriple negative breast cancercarboplatinNeoadjuvant therapybusinessResearch Paper
researchProduct

The Use of Hypomethylating Agents (HMAs) in Patients with Relapsed and Refractory Acute Myeloid Leukemia (RR-AML): Clinical Outcomes and Their Predic…

2016

Abstract Introduction: Patients with RR-AML, particularly older adults, have dismal outcomes and limited therapy options. Given low response rates and high toxicity with salvage intensive chemotherapy, and frequent ineligibility for allogeneic stem cell transplantation (alloSCT), many patients are treated with HMAs. Robust data regarding use of HMAs in AML predominates in the frontline setting, while their use in RR-AML has limited supportive data. Here wesought to analyze theoutcomes and their predictors in patients with RR-AML treated with HMAs. Methods:We collected data, spanning a period from 2006 to 2016, from 7 centers in the United States and 4 centers in Europe regarding patients tr…

0301 basic medicinemedicine.medical_specialtybusiness.industryImmunologyComplete remissionDecitabineCell BiologyHematologyBiochemistryTransplantationClinical trial03 medical and health sciences030104 developmental biology0302 clinical medicineRefractoryInterquartile range030220 oncology & carcinogenesisInternal medicineCohortmedicineIn patientbusinessmedicine.drugBlood
researchProduct

Efficient Online Laplacian Eigenmap Computation for Dimensionality Reduction in Molecular Phylogeny via Optimisation on the Sphere

2019

Reconstructing the phylogeny of large groups of large divergent genomes remains a difficult problem to solve, whatever the methods considered. Methods based on distance matrices are blocked due to the calculation of these matrices that is impossible in practice, when Bayesian inference or maximum likelihood methods presuppose multiple alignment of the genomes, which is itself difficult to achieve if precision is required. In this paper, we propose to calculate new distances for randomly selected couples of species over iterations, and then to map the biological sequences in a space of small dimension based on the partial knowledge of this genome similarity matrix. This mapping is then used …

0303 health sciences[STAT.AP]Statistics [stat]/Applications [stat.AP]Computer scienceDimensionality reductionComputationDimension (graph theory)Complete graphMinimum spanning treeBayesian inferenceQuantitative Biology::Genomics03 medical and health sciencesComputingMethodologies_PATTERNRECOGNITION0302 clinical medicine[STAT.ML]Statistics [stat]/Machine Learning [stat.ML]Algorithm030217 neurology & neurosurgeryEigenvalues and eigenvectorsDistance matrices in phylogenyComputingMilieux_MISCELLANEOUS030304 developmental biology
researchProduct

Impact of Donor Type on Outcome after Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients: Analysis of the German-Austrian Acute …

2014

Abstract Background:Despite recent advances in identifying novel molecular targets in AML patients, intensive chemotherapy followed by allogeneic hematopoietic stem cell transplantation (HSCT) still remains a cornerstone of AML therapy. However, outcome of HSCT depends on the availability of a donor and the donor type. Prior studies comparing HSCT from HLA-matched related donors (MRD) with matched unrelated donors (MUD), demonstrated conflicting results with regards to outcome. These conflicting results might be attributed to the genetic heterogeneity of AML. Aims:To analyze outcome with respect to donor type of 952 AML patients who received HSCT in first complete remission (CR) and were tr…

0303 health sciencesmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentImmunologySignificant differenceComplete remissionMyeloid leukemiaCell BiologyHematologyHematopoietic stem cell transplantationBiochemistry3. Good healthTransplantation03 medical and health sciences0302 clinical medicineRisk groupsInternal medicineMolecular targetsmedicineCumulative incidencebusiness030304 developmental biology030215 immunologyBlood
researchProduct

Optimizing Query Perturbations to Enhance Shape Retrieval

2020

3D Shape retrieval algorithms use shape descriptors to identify shapes in a database that are the most similar to a given key shape, called the query. Many shape descriptors are known but none is perfect. Therefore, the common approach in building 3D Shape retrieval tools is to combine several descriptors with some fusion rule. This article proposes an orthogonal approach. The query is improved with a Genetic Algorithm. The latter makes evolve a population of perturbed copies of the query, called clones. The best clone is the closest to its closest shapes in the database, for a given shape descriptor. Experimental results show that improving the query also improves the precision and complet…

050101 languages & linguisticsComputer scienceInformationSystems_INFORMATIONSTORAGEANDRETRIEVALPopulationComputingMethodologies_IMAGEPROCESSINGANDCOMPUTERVISION02 engineering and technology[INFO.INFO-AI]Computer Science [cs]/Artificial Intelligence [cs.AI]Search engineCompleteness (order theory)Genetic algorithm0202 electrical engineering electronic engineering information engineering0501 psychology and cognitive sciences[INFO]Computer Science [cs]educationMassively parallelComputingMilieux_MISCELLANEOUSThesaurus (information retrieval)education.field_of_studyCloning (programming)business.industry05 social sciencesPattern recognitionKey (cryptography)020201 artificial intelligence & image processingArtificial intelligencebusiness
researchProduct

Magic informationally complete POVMs with permutations

2017

Eigenstates of permutation gates are either stabilizer states (for gates in the Pauli group) or magic states, thus allowing universal quantum computation [M. Planat and Rukhsan-Ul-Haq, Preprint 1701.06443]. We show in this paper that a subset of such magic states, when acting on the generalized Pauli group, define (asymmetric) informationally complete POVMs. Such IC-POVMs, investigated in dimensions $2$ to $12$, exhibit simple finite geometries in their projector products and, for dimensions $4$ and $8$ and $9$, relate to two-qubit, three-qubit and two-qutrit contextuality.

1003permutation groups159informationally complete povmsFOS: Physical sciences01 natural sciences157[SPI.MAT]Engineering Sciences [physics]/Materialslaw.inventionCombinatorics81P50 81P68 81P13 81P45 20B05Permutationlaw0103 physical sciences1009[SPI.NANO]Engineering Sciences [physics]/Micro and nanotechnologies/Microelectronics010306 general physicslcsh:ScienceEigenvalues and eigenvectorsQuantum computer[SPI.ACOU]Engineering Sciences [physics]/Acoustics [physics.class-ph]PhysicsQuantum Physics120Multidisciplinary010308 nuclear & particles physicsPhysicsMagic (programming)Q Science (General)16. Peace & justiceKochen–Specker theoremProjectorfinite geometryPauli groupquantum contextualitylcsh:QPreprintmagic statesQuantum Physics (quant-ph)Research Article
researchProduct

Differences in Participation and Performance Trends in Age Group Half and Full Marathoners

2014

International audience; Recent studies investigated participation and performance trends in age group half marathoners and full marathoners for a single event. The present study investigated participation and performance trends in age group athletes in all half marathons and full marathons held in a single country during a given period of time. Changes in running performance and age of 226,754 half marathoners and 86,419 full marathoners competing in Switzerland between 2000 and 2010 were analyzed using linear regression analyses. The number of half marathoners increased (P < 0.01) from 2000 to 2010 for both men (+231%) and women (+299%). In contrast, the number of male and female full mara…

11035 Institute of General PracticeGerontologyAdultMaleComplete dataPhysiologyTRAINING CHARACTERISTICS610 Medicine & healthAthletic PerformanceRunning2737 Physiology (medical)Sex FactorsAge groupsSex factorsPhysiology (medical)MedicineHumansSKINFOLD THICKNESSESDECLINEHYPONATREMIAbusiness.industryAge Factors1314 PhysiologyMiddle AgedRUNNERSPhysical EnduranceFemale[ SCCO ] Cognitive scienceRUNNING PERFORMANCEbusinessSwitzerland
researchProduct